Successful medical treatment of infective endocarditis caused by Candida parapsilosis in an immunocompromised patient
- PMID: 26452742
- PMCID: PMC4600772
- DOI: 10.1136/bcr-2015-212128
Successful medical treatment of infective endocarditis caused by Candida parapsilosis in an immunocompromised patient
Abstract
Candida spp is a common pathogen of nosocomial infections that has increased in recent decades, with mortality rates close to 40% in cases of systemic candidiasis. One type of presentation is infective endocarditis, which, by its prolonged need for treatment, represents a constant challenge for clinicians. We describe a 36-year-old woman, recently diagnosed with ovarian cancer, who developed aortic valve infective endocarditis caused by Candida parapsilosis and who was treated with oral antifungal medication, with no surgical intervention required.
2015 BMJ Publishing Group Ltd.
Figures
References
-
- Nishimura RA, Otto CM, Bonow RO et al. , American College of Cardiology; American College of Cardiology/American Heart Association; American Heart Association. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg 2014;148:e1–132. 10.1016/j.jtcvs.2014.05.014 - DOI - PubMed
-
- Almirante B, Rodríguez D, Cuenca-Estrella M et al. . Epidemiology, risk factors, and prognosis of Candida parapsilosis bloodstream infections: case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003. J Clin Microbiol 2006;44:1681–5. 10.1128/JCM.44.5.1681-1685.2006 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous